Condition: Preeclampsia (PE) · Sponsor: Assistance Publique - Hôpitaux de Paris
The purpose of this study is to determine whether first-trimester screening for preeclampsia based on the FMF algorithm (a combination of maternal clinical, sonographic and biochemical parameters), improves maternal or perinatal health.
This description comes directly from the study's public registry record.
Vassilis TSATSARIS, MD, PhD · 01 58 41 38 71 · vassilis.tsatsaris@aphp.fr
Valérie PLENCE, MSc · 01 58 41 11 78 · valerie.plence-fauroux@aphp.fr
Always discuss trial participation with your own doctor first.
| CHU Angers | Angers, France | Recruiting |
| CHU de Bordeaux | Bordeaux, France | Recruiting |
| Hôpital Femme Mère Enfant | Bron, France | Recruiting |
| Hôpital Antoine Béclère | Clamart, France | Recruiting |
| CHU Estaing | Clermont-Ferrand, France | Recruiting |
| Hôpital Intercommunal Créteil | Créteil, France | Recruiting |
| CHU Dijon Bourgogne | Dijon, France | Recruiting |
| CHU Lille | Lille, France | Recruiting |
| Hôpital de la conception et de la Timone | Marseille, France | Recruiting |
| Hôpital Nord | Marseille, France | Recruiting |
| CHRU de Nancy | Nancy, France | Recruiting |
| Hôpital Femme - Maternité | Nantes, France | Recruiting |
+ 10 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05521776